Elevated p53 and lower MDM2 expression in hippocampus from patients with intractable temporal lobe epilepsy
- 31 December 2007
- journal article
- research article
- Published by Elsevier BV in Epilepsy Research
- Vol. 77 (2-3), 151-156
- https://doi.org/10.1016/j.eplepsyres.2007.09.001
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (NS39016, NS41935)
- Health Research Board (PD/2005/35, RP/2005/24)
- Science Foundation Ireland (04/IN3/B466)
This publication has 21 references indexed in Scilit:
- Neuronal apoptosis in the resected sclerotic hippocampus in patients with mesial temporal lobe epilepsyJournal of Clinical Neuroscience, 2007
- Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsyExperimental Neurology, 2006
- Regulating the p53 pathway: in vitro hypotheses, in vivo veritasNature Reviews Cancer, 2006
- Caspase-3 Cleavage and Nuclear Localization of Caspase-Activated DNase in Human Temporal Lobe EpilepsyJournal of Cerebral Blood Flow & Metabolism, 2005
- Epilepsy and Apoptosis PathwaysJournal of Cerebral Blood Flow & Metabolism, 2005
- p53, apoptosis and axon-guidance moleculesCell Death & Differentiation, 2005
- p53: 25 years after its discoveryTrends in Pharmacological Sciences, 2004
- Expression, interaction, and proteolysis of death‐associated protein kinase and p53 within vulnerable and resistant hippocampal subfields following seizuresHippocampus, 2004
- Progressive neocortical damage in epilepsyAnnals of Neurology, 2003
- Recurrent seizures may cause hippocambal damage in temporal lobe epilepsyNeurology, 1998